Charles Schwab’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.09M Sell
602,966
-7,962
-1% -$58.9K ﹤0.01% 2486
2025
Q4
$7.11M Buy
610,928
+26,446
+5% +$292K ﹤0.01% 2294
2025
Q3
$6.8M Buy
584,482
+389,027
+199% +$4.7M ﹤0.01% 2293
2025
Q2
$2.41M Buy
195,455
+18,267
+10% +$202K ﹤0.01% 2610
2025
Q1
$1.09M Buy
177,188
+2,770
+2% +$28.7K ﹤0.01% 2808
2024
Q4
$1.41M Buy
174,418
+17,869
+11% +$178K ﹤0.01% 2791
2024
Q3
$1.26M Hold
156,549
﹤0.01% 2850
2024
Q2
$678K Buy
156,549
+12,132
+8% +$61.6K ﹤0.01% 3067
2024
Q1
$612K Sell
144,417
-6,877
-5% -$23.8K ﹤0.01% 2953
2023
Q4
$569K Buy
151,294
+8,040
+6% +$27.7K ﹤0.01% 3029
2023
Q3
$530K Buy
143,254
+18,651
+15% +$74.2K ﹤0.01% 3018
2023
Q2
$494K Buy
124,603
+101,999
+451% +$505K ﹤0.01% 3058
2023
Q1
$93.6K Buy
22,604
+8,656
+62% +$35.4K ﹤0.01% 3260
2022
Q4
$58.9K Hold
13,948
﹤0.01% 3329
2022
Q3
$40K Hold
13,948
﹤0.01% 3381
2022
Q2
$57K Sell
13,948
-84,742
-86% -$315K ﹤0.01% 3376
2022
Q1
$541K Buy
98,690
+4,401
+5% +$20.2K ﹤0.01% 3076
2021
Q4
$430K Hold
94,289
﹤0.01% 3191
2021
Q3
$439K Hold
94,289
﹤0.01% 3181
2021
Q2
$647K Buy
94,289
+11,711
+14% +$93.2K ﹤0.01% 3082
2021
Q1
$825K Buy
82,578
+1,997
+2% +$21K ﹤0.01% 2913
2020
Q4
$599K Buy
80,581
+10,823
+16% +$73.6K ﹤0.01% 2922
2020
Q3
$421K Buy
69,758
+6,806
+11% +$34.2K ﹤0.01% 2923
2020
Q2
$397K Buy
62,952
+3,060
+5% +$14.2K ﹤0.01% 2920
2020
Q1
$216K Hold
59,892
﹤0.01% 2993
2019
Q4
$437K Buy
59,892
+4,911
+9% +$30K ﹤0.01% 2871
2019
Q3
$351K Hold
54,981
﹤0.01% 2930
2019
Q2
$494K Buy
+54,981
New +$431K ﹤0.01% 2816
2019
Q1
Sell
-5,920
Closed -$39K 3194
2018
Q4
$39K Buy
+5,920
New +$39.6K ﹤0.01% 3135
2016
Q2
Sell
-9,075
Closed -$121K 3116
2016
Q1
$121K Hold
9,075
﹤0.01% 2969
2015
Q4
$93K Hold
9,075
﹤0.01% 3045
2015
Q3
$91K Hold
9,075
﹤0.01% 3043
2015
Q2
$177K Buy
+9,075
New +$311K ﹤0.01% 2997

Other funds holding CRMD